2019 rate card - cap today...see our digital edition at . com/mag in addition, cap today advertisers...
TRANSCRIPT
Frequency 1x 4x 6x 12x 18x 24x 36x 48x 60x
Tabloid 6,680 6,520 6,380 6,140 5,930 5,760 5,500 5,400 5,300
2/3 Tabloid 5,910 5,670 5,470 5,140 4,950 4,750 4,570 4,420 4,200
1/2 Tabloid 4,890 4,800 4,610 4,510 4,310 4,160 3,980 3,900 3,750
1/3 Tabloid 3,350 3,230 3,080 3,020 2,960 2,930 2,840 2,740 2,580
1/4 Tabloid 3,160 3,030 2,930 2,820 2,620 2,560 2,400 2,330 2,230
Standard 5,250 5,140 5,020 4,710 4,570 4,360 4,160 4,000 3,920
2/3 Standard 3,350 3,230 3,080 3,020 2,960 2,930 2,840 2,740 2,580
1/2 Standard 2,890 2,800 2,680 2,590 2,480 2,420 2,340 2,270 2,160
1/3 Standard 2,270 2,200 2,090 1,830 1,780 1,670 1,610 1,530 1,480
1/4 Standard 1,660 1,580 1,530 1,450 1,390 1,330 1,270 1,240 1,190
Advertising Rates Commission: 15% to recognized agencies Inserts: Consult Advertising Director
4-color 1,400
2nd color matched from
process700
5th color or Pantone 900
Color
Ads produced with combinations of process inks (cyan, magenta, yellow, and black) use color most economically. Many Pantone (PMS) specified colors can often be approximated using process inks. CAP TODAY can help you plan the most efficient use of your color. Call Keith Eilers, 847-832-7528, for specific information. Circulation Frequency: Monthly Mailing: Periodical Class
Publisher/Sales Office Bob McGonnagle 325 Waukegan Road, Northfield, IL 60093 Phone: 847-832-7476; Fax: 847-832-8153 [email protected]
Production Keith Eilers, Managing Periodicals Editor 325 Waukegan Road, Northfield, IL 60093 Phone: 847-832-7528; Fax: 847-832-8528 [email protected]
Jane Ure, Production Editor 325 Waukegan Road, Northfield, IL 60093 Phone: 847-832-7980; Fax: 847-832-8980 [email protected]
Advertising Directors East: Hally Birnbaum Mount Kisco, NY Phone: 914-218-1943; Fax: 847-832-8153 [email protected]
Midwest: Lori Prochaska Omaha, NE Phone: 402-290-7670; Fax: 847-832-8153 [email protected]
West: Diana Kelker Sacramento, CA Phone: 847-832-7749; Fax: 847-832-8749 [email protected]
Classified KERH Group, PO Box 207 Parker Ford, PA 19457 Phone: 888-489-1555 [email protected]
2019 RATE CARD
Every month CAP TODAY brings essential news to all keydecision-makers responsible for clinical laboratory purchases.This news includes advances in tests and equipment, trends in management and clinical operation, regulatory changes, and fi nance, plus news about the laboratory improvement programs of the College of American Pathologists.
Independent research studies show that CAP TODAY is #1in total ad exposures for the marketplace. Kantar Media Healthcare Research has
completed new studies on pathologists, clinical lab directors, lab managers and administrators, section managers and
supervisors, and total hospital purchasing infl uence. In 2018, CAP TODAY carried more advertising than any other book in the fi eld.
Essential monthly reporting on the clinical laboratory for lab managersand administrators, physicians, lab directors, and supervisory technologists.
Distribution
Readers* All key decision-makers, no excess
Pathologists and Laboratory Directors 17,000Laboratory Managers and Laboratory Administrators 5,000Chief Techs; Section Managers/Supervisors of Chemistry, Hematology, Microbiology, Immunology, Blood Bank, Cytology, or Histotechnology
22,000
TOTAL 44,000* This listing is specially grouped for convenience. See the BPA Publisher’s Statement for detailed circulation data.
Proven ResearchCAP TODAY offers the most thorough research in the fi eld. This allows advertisers to understand exactly how CAP TODAY delivers messages to the various professional titles and personnel in the circulation and serves to explain the laboratory market.Ask for copies or, better, presentations of studies on:1. Pathologist readership2. Readership by section managers and supervisors—often the backbone of your lab contacts and relationships3. Portrait of the clinical laboratory—purchasing and personnel data and readership by lab directors and lab administrators4. Purchasing infl uence—hospital executives tell us how their institutions acquire a range of lab products and services
Combined Frequency DiscountsInsertions in CAP TODAY and the Archives of Pathology & Laboratory Medicine combine to determine the earned rate in each publication. Call your representative for details.
Digital AdvertisingPrint advertisers receive value-added online ads. See our digital edition at www.captodayonline.com/mag In addition, CAP TODAY advertisers have exclusive digital advertising opportunities available. Please see separate CAP TODAY 2019 Digital offerings.exclusive digital advertising opportunities available.
Archives of Pathology
exclusive digital advertising opportunities available.
Special Section—Updated CAP, IASLC, and AMP Molecular Lung Cancer Testing Guideline; Updates From the 2016 Molecular
Cytopathology Meeting (Napoli, Italy), Part I
March 2018
Anaplastic Lymphoma Kinase Gene Rearrangement by Fluorescence In Situ
Hybridization in Non-Small Cell Lung Cancer on Direct Smears
Special Section—Updated CAP, IASLC, and AMP Molecular Lung Cancer Testing Guideline; Updates From the 2016 Molecular
Cytopathology Meeting (Napoli, Italy), Part I
March 2018
Anaplastic Lymphoma Kinase Gene Rearrangement by Fluorescence In Situ
Hybridization in Non-Small Cell Lung Cancer on Direct Smears
AD-MARK In 2019, CAP TODAY will test all ads in the February, June, and November issues. This service provides direct feedback from readers as to how an ad is received. Companies can track how an ad stacks up to others in the same product category, evaluate the half-life of an ad that has been running, and perform valuable benchmarking for new campaigns. Ask your representative for details.
◆◆◆ ReadEx Red Sticker Study October 2019 issue. The Red Sticker Study examines multiple facets of readers’ attitudes to ads—includes verbatim com-ments and measures of attention, appeal, and reading.List rental CAP TODAY makes its list available to advertisers at nominal rates. Ask your representative for details.Merchandising CAP TODAY can provide assistance to advertisers throughcustomized research projects and sales support efforts.
Reprints CAP TODAY reprints make valuable sales aids for the fi eld. Contact Production Editor Jane Ure at 847-832-7980 or [email protected] syndicated media research on readership and ad placement. CAP TODAY participates in and can share results from independent media research on readership and ad placement in the clinical laboratory marketplace. Such media research is often the best aid in planning the most effective ad schedule. Ad placement and spending data for the market help establish essential metrics.Digital extras All advertisements in CAP TODAY are mirrored each month in the digital edition, at www.captodayonline.com/mag. Please provide your advertising director preferred target URL.
Services to advertisers
BD Diagnostics FILE— NEW AUGUST 2018 page 3
Automated workflow and decision-making
Informed staffing and workload management
On-demand analytics and remote access
• Rules engine streamlines workflow management
• Flags clinically significant results for review
• Drives informed standardization of lab testing practices
• Remote image reading allows anywhere, anytime access for any number of users
• Intuitive interface enables customizable dashboards and worklists
• Easy workload allocation focuses staff on key activities, impacting productivity and turnaround time
• Remote access enables consults as needed, potentially impacting turnaround time
• Comprehensive analytics drive laboratory efficiency and lean workflows
• Designed to support strong data security and privacy controls
Discover how BD Kiestra™ solutions and the BD Synapsys™ microbiology informatics solution combine to transform microbiology and improve laboratory outcomes. Learn more at bd.com/synapsys.© 2018 BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company. BD, 7 Loveton Circle, Sparks, MD 21152-0999 USA Tel: 1.800.638.8663 bd.com
Connecting, integrating and empowering BD Kiestra™ Solutions to transform microbiology and improve laboratory outcomes.
The BD Synapsys™ informatics solution helps elevate laboratory automation performance through a secure and scalable integrated informatics platform.
BD Kiestra™ Solutions empowered by BD Synapsys™ Microbiology Informatics
22 in Bleed21.75 in Trim
14.1
25 in
Ble
ed13
.875
in T
rim
BD Diagnostics FILE— NEW AUGUST 2018 page 2 0818_TABs-Agena-Denka-12.indd 2 8/1/18 11:38 AM BD Diagnostics FILE— NEW AUGUST 2018 page 3
Automated workflow and decision-making
Informed staffing and workload management
On-demand analytics and remote access
• Rules engine streamlines workflow management
• Flags clinically significant results for review
• Drives informed standardization of lab testing practices
• Remote image reading allows anywhere, anytime access for any number of users
• Intuitive interface enables customizable dashboards and worklists
• Easy workload allocation focuses staff on key activities, impacting productivity and turnaround time
• Remote access enables consults as needed, potentially impacting turnaround time
• Comprehensive analytics drive laboratory efficiency and lean workflows
• Designed to support strong data security and privacy controls
Discover how BD Kiestra™ solutions and the BD Synapsys™ microbiology informatics solution combine to transform microbiology and improve laboratory outcomes. Learn more at bd.com/synapsys.© 2018 BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company. BD, 7 Loveton Circle, Sparks, MD 21152-0999 USA Tel: 1.800.638.8663 bd.com
Connecting, integrating and empowering BD Kiestra™ Solutions to transform microbiology and improve laboratory outcomes.
The BD Synapsys™ informatics solution helps elevate laboratory automation performance through a secure and scalable integrated informatics platform.
BD Kiestra™ Solutions empowered by BD Synapsys™ Microbiology Informatics
22 in Bleed21.75 in Trim
14.1
25 in
Ble
ed13
.875
in T
rim
BD Diagnostics FILE— NEW AUGUST 2018 page 2 0818_TABs-Agena-Denka-12.indd 3 8/1/18 11:38 AM
PATHOLOGY ◆ LABORATORYMEDICINE ◆ LABORATORYMANAGEMENT JANUARY 2018
Vo
l. 32, N
o. 1
Mo
vin
g?
Fax
a c
opy
of th
e be
low
addr
ess
with
cor
rect
ions
to C
AP
TO
DAY
: 847
-832
-815
3.
Jenn
ifer
Altm
an
Clin Lab 2.0: Add value, make patients better
Anne Paxton
It was baseball’s Yogi Berra who said, with the
unique slant that was his hallmark, “In theory there
is no difference between theory and practice. In
practice, there is.” More vividly, boxer Mike Tyson
once summed up the same reality when asked to
comment on an opponent’s strategy
in an upcoming match: “Everybody
has a plan—until they get hit.”
Laboratories may not have to fear
such a sudden and traumatic hour of
reckoning. But as new payment mod-
els change volume-based health care
to value-based health care, these sports
lessons are relevant to the laboratory
industry’s strategic planning. If add-
ing value, in theory, is becoming es-
sential to laboratories’ survival, what
does that mean they should do, in
practical terms?
To explore the next era for health
care and what it means for labs, CEOs
and directors from Geisinger Health,
Henry Ford Health System, North-
well Health Laboratories, Kaiser Per-
manente North Laboratories, and
TriCore Reference Laboratories began
meeting in March 2016 as “Project Santa Fe.” They
see their concept of Clinical Laboratory 2.0, empha-
sizing demonstration of how the laboratory adds
value to patient care, as a critical clinical and busi-
ness model for re-engineering laboratories’ role in
the health care system.
“The value discussion has been underway for
some years,” says founding member James Craw-
ford, MD, PhD, senior vice president of laboratory
services at Northwell Health in the greater New York
metropolitan area. “Project Santa Fe was founded to
bring together like-minded
Genotype-guided dosing of warfarin: GIFT wrap-up
Elizabeth Silverman
In an ideal world, clinical research
data would be applied with immedi-
ate and beneficial effect to clinical
practice, especially when the data
come from a well-controlled, well-run
trial that meets the gold standard of
being large, randomized, and blind-
ed. However, as the Sept. 26 publica-
tion of the Genetic Informatics Trial to
evaluate genotype-guided dosing of
warfarin demonstrates, reality is far
more complicated (Gage BF, et al.
JAMA. 2017;318[12]:1115–1124).
Despite GIFT showing that geno-
type-guided dosing prevents more
adverse outcomes than clinically
guided dosing, pharmacogenetic test-
ing to improve warfarin initiation
may not become wide-
spread practice anytime
soon.GIFT was designed to
do what the earlier
COAG and EU-PACT
trials had failed to do:
provide the definitive
answer to the question
of whether genotype-guided warfarin
dosing provided statistically signifi -
cant clinical benefi t to patients under-
going anticoagulant therapy. The in-
consistent results of
POC glucose testing in the critically ill
Lab options, latest studies, one lab’s program Page 10
—continued on 47
Next-gen sequencing
fi nds further clinical
utility in oncologyWilliam Check, PhD
One of the plenary sessions at the
2017 meeting of the Association for
Molecular Pathology—“High Impact
Molecular Diagnostics for Cancer
and Inherited Diseases”—was a vir-
tual mini-course in the latest and
most useful applications of next-
generation sequencing to detect
germline and somatic mutations in
cancer. Both speakers zeroed in on
the clinical utility of their innovative
diagnostic techniques.
A. John Iafrate, MD, PhD, ad-
dressed the expanding use of NGS to
guide targeted therapies in lung can-
cer. Dr. Iafrate, a pathologist at Mas-
sachusetts General Hospital, medical
director of its Center for Integrated
Diagnostics, and a professor at Har-
vard Medical School, focused on
detecting the —continued on 42
—continued on 18
Sara Enders and Steven Cotten, PhD
Dr. James Crawford (right) with (from left) Reeti Khare,
PhD, assistant director of infectious disease diagnostics;
Tarush Kothari, MD, MPH, physician informaticist; and
Yehuda Jacobs, software architect. The question Dr.
Crawford asks his laboratory colleagues is, “Can you
demonstrate that patients are better for having received
care from your lab as opposed to from other labs?”
0118_1-48_SantaFe-MolecDx-Gift_2.indd 1
1/9/18 3:42 PM
Product Guides Detailed charts provide criteria essential to lab directors, administrators, and managers. Product guide listings, an editorial feature, are always free and companies provide the content for their listings, including contact information.
Independent ResearchAD-MARK is a readership and advertising study. Advertise and get a comparative report on your ad and every ad in the issue.
◆◆◆ ReadEx Red Sticker Study examines multiple facets of readers’ attitudes to ads—includes verbatim comments and measures of attention, appeal, and reading.
What others are saying about CAP TODAYAll categories of lab professionals consistently rate CAP TODAY“Most important to my job.”
Ranks No.1 in Readership and Ad Exposures for: (1) pathologists and medical lab directors; (2) clinical laboratory section managers and supervisors; and (3) lab directors, managers, and lab administrators in hospitals with 100+ bedsand independent labs.
Digital and Mobile AccessSee our digital rate card www.captodayonline.com/2019/Advertising/2019_CAPTODAYDigital_RateCard.pdf
2019 CAP TODAY Media Planner2019Issues
BonusDistribution
Instrument/SoftwareProduct Guides What’s inside CAP TODAY: Editorial Planner*
January Texas Society of Pathologists(Austin)
HIMSS (Orlando)
Coagulation analyzers Editorial: 20–25 editorial items, highlighted by in-depth, front-cover features with long story continuations that support back-and-forth reading patterns—readers return to the front cover up to three times.
Interviews with experts from forefront institutions who discuss up-to-the-minute advances (some new, some tried and true) in anatomic, clinical, and molecular pathology and dozens of subspecialties.
Special Laboratory Accreditation Program updates.
Q&A: Covering all lab disciplines, with answers provided by experts. Placed at the back of the magazine, this section is one of the best read.
Newsbytes: Software and technology news—a great spot to showcase IT-related products.
Selected Abstracts: Clinical, anatomic, and molecular abstracts of relevant peer-reviewed papers—editorial that receives extremely high readership scores every month.
Classifi eds: The source for targeting laboratory professionals, products, and services.
Marketplace: An extensive multi-page spread of innovative laboratory products and vendor news.
Put It on the Board: Highlightsof legislative, association, and industry developments presented in concise, easy-to-read news capsules.
Cytopathology and More:A special section featuring what’s new, published three times per year.
Parasitic infection-surgical pathologyTuberculosis-sequencing for
susceptibilityCoagulationCytopathology
February DMT Conference withMike Laposata (Galveston)
USCAP (Washington, DC)
Anatomic pathologycomputer systems
Tumor board—breastCase report—lung adenocarcinomaToxicology
March AACR (Atlanta)
CLMA (Dallas)
Bedside glucosetesting systems
Peripheral blood smear evaluationLung disease
April Executive War College (New Orleans)
Clinical Virology Symposium (Savannah, GA)Pathology Informatics (Pittsburgh)
Molecular testing for STDsLiquid biopsy
May ASCO (Chicago) Next-generation sequencing Bacterial sepsisNext-generation sequencingCytopathology
June ASM (San Francisco)
AACC Preview
Chemistry/Immunoassay analyzers low-volumeand POC
Point-of-care testingMeningitis/encephalitisGenomic testing–clinical vs. consumer
July AACC (Anaheim) Chemistry/Immunoassay ana-lyzers mid- to high-volume
Cutaneous lymphomasDiabetesTest distribution in large systems
August ASCP (Phoenix) Breast pathologySepsis and procalcitoninCytopathology
September NSH (New Orleans)
CAP19 (Orlando)
Pathology Visions (Orlando)
Digital pathologyBilling services and systemsAP core labs
October AABB (San Antonio)
AMP (Baltimore)
Hematology analyzers TransfusionNew tests in hematologyPOC update
November ASC (Salt Lake City)
ASH (Orlando)
Laboratory information systems
HbA1c testing
Flu testing
Update on expert rules
December Urinalysis systems Urinalysis and body fl uidsDiabetes
AD-MARK
AD-MARK
◆◆◆ ReadEx RedSticker Study
AD-MARK
*Five weeks before reservation deadlines, CAP TODAY sales representatives can forecast the more complete and detailed monthly lineup. *EDITORIAL PLANNER SUBJECT TO CHANGE
AD SIZES
Nominal Live Area for Non-Bleed Ads
Bleed Ads*
Trim Bleed
Width Depth Width Depth Width Depth
A Tabloid King 101/8” 127/8” 107/8” 137/8” 111/8” 141/8”
B Tabloid Spread 21” 127/8” 213/4” 137/8” 22” 141/8”
C 5th Col Spread 13” 127/8” 133/8” 137/8” 135/8” 141/8”
D 2/3 Tabloid Square 101/8” 101/4” 107/8” 107/8” 111/8” 111/8”
E 1/2 Tabloid Vertical 43/4” 127/8” 53/8” 137/8” 55/8” 141/8”
F 1/2 Tabloid Horizontal 101/8” 71/8” 107/8” 73/4” 111/8” 8”
G+ 1/3 Tabloid Vertical 3” 127/8” 33/4” 137/8” 4” 141/8”
G 1/4 Tabloid Vertical 21/4” 127/8” 27/8” 137/8” 31/8” 141/8”
H 1/2 Tabloid Horizontal Spread 21” 71/8” 213/4” 73/4” 22” 8”
I Standard “A” Page 71/2” 101/4” 77/8” 107/8” 81/8” 111/8”
J Standard “A” Spread 15” 101/4” 15” 107/8” 151/4” 111/8”
K 2/3 Standard Island 43/4” 101/4” 53/8” 107/8” 55/8” 111/8”
L 1/2 Standard Vertical 31/2” 101/4” 4” 107/8” 41/4” 111/8”
M 1/2 Standard Island 43/4” 81/2” 53/8” 91/8” 55/8” 91/4”
N 1/2 Standard Horizontal 73/8” 51/2” 77/8” 6” 81/8” 61/4”
O 1/3 Standard Vertical 21/4” 101/4” 27/8” 107/8” 31/8” 111/8”
P 1/3 Standard Square 43/4” 43/4” 53/8” 53/8” 55/8” 55/8”
Q 1/4 Standard Island 31/2” 5” 4” 55/8” 41/4” 57/8”
R 1/4 Standard Horizontal 73/8” 21/2” 77/8” 31/8” 81/8” 31/4”
S 1/4 Standard Vertical 21/4” 81/2” 27/8” 91/8” 31/8” 91/4”
T 2/3 Standard Banner 101/8” 43/4” 107/8” 51/4” 111/8” 51/2”
U 1/2 Standard Banner 101/8” 33/4” 107/8” 41/4” 111/8” 41/2”
V 1/3 Standard Banner 101/8” 23/4” 107/8” 31/4” 111/8” 31/2”
W 1/4 Standard Banner 101/8” 17/8” 107/8” 21/2” 111/8” 23/4”
*Crop and register marks offset should be set 1/4” beyond trim. Live type is recommended to maintain at least 1/4” space inside trimming edges.
2019 CAP TODAY Mechanical RequirementsIf you have questions about file production or transfer, please contact Keith Eilers at 847-832-7528 or e-mail [email protected] dates: Insertion Orders: 4th of month preceding issue date. Materials: 14th of month preceding issue date.
A CBD
E
F
G
HI J K L
M N
O
QP RS
WVUT
G+